You are viewing the site in preview mode
Skip to main content
| |
Single history (n=12)
|
Repeaters (n=11)
|
p-value
|
|---|
|
Sex (male, %)
|
50
|
72.7
|
0.265
|
|
Age at PD initiation (median, years)
|
64 [63–77]
|
59 [53–84]
|
0.423
|
|
Performance status at PD initiation (0–4) (n)
|
0 (9)
|
0 (7)
|
N/A
|
|
1 (2)
|
1 (3)
|
|
2 (1)
|
2(0)
|
|
3(0)
|
3 (1)
|
|
4(0)
|
4(0)
|
|
Diabetes* (%)
|
58.3
|
27.3
|
0.133
|
|
Hypertension (%)
|
22.5
|
37.5
|
0.205
|
|
Serologic tests time average concentration
|
|
Albumin* (median, g/dL)
|
3.6 [3.4–3.8]
|
3.6 [3.0–3.9]
|
0.594
|
|
Potassium* (median, mEq/L)
|
4.3 [3.9–4.8]
|
4.1 [3.7–4.4]
|
0.346
|
|
Magnesium (median, mg/dL)
|
2.1 [2.0–2.3]
|
2.1 [1.8–2.2]
|
0.451
|
|
Corrected calcium (median, mg/dL)
|
9.3 [8.8–9.4]
|
9.2 [8.8–9.5]
|
0.974
|
|
Inorganic phosphorus (median, mg/dL)
|
4.9 [4.4–5.2]
|
5.1 [4.7–6.0]
|
0.281
|
|
Intact PTH (median, pg/mL)
|
290 [171–431]
|
288 [215–343]
|
0.985
|
|
Use of medications
|
|
RAS blocker (%)
|
41.7
|
35.7
|
0.722
|
|
Calcium channel blocker (%)
|
75.0
|
46.4
|
0.096
|
|
Diuretic (%)
|
91.7
|
75.0
|
0.227
|
|
Oral vitamin D* (%)
|
58.3
|
53.6
|
0.782
|
|
Dose of oral vitamin D (μg/day)
|
0.35±0.31
|
0.25±0.28
|
0.443
|
|
Vitamin D started with SHPTH (%)
|
66.7
|
53.6
|
0.563
|
|
Phosphate binder (%)
|
83.3
|
75.0
|
0.443
|
|
Precipitated calcium carbonate (%)
|
50.0
|
53.6
|
0.836
|
|
Non-calcium-containing phosphate binder (%)
|
50.0
|
50.0
|
1.000
|
|
Calcimimetics (%)
|
0
|
25.0
|
0.057
|
|
Laxative* (%)
|
16.7
|
14.3
|
0.847
|
|
Erythropoiesis-stimulating agent (%)
|
91.7
|
96.4
|
0.527
|
|
Immunosuppressant* (%)
|
8.3
|
0
|
0.122
|
|
Other factors
|
|
PD against patient’s choice* (%)
|
8.3
|
9.1
|
0.949
|
|
Smoking history* (%)
|
41.7
|
27.3
|
0.469
|
|
Indoor pet breeding* (%)
|
8.3
|
27.3
|
0.231
|
|
Psychiatric disorder* (%)
|
8.3
|
27.3
|
0.231
|
|
Public assistance* (%)
|
0
|
9.1
|
0.286
|
|
Assisted PD (%)
|
8.3
|
27.3
|
0.231
|
|
Use of exchange devise (%)*
|
91.7
|
90.9
|
0.949
|
|
Living environment (apartment, %)*
|
41.7
|
45.5
|
0.855
|
|
Job (%)*
|
25.0
|
36.4
|
0.554
|
- PD peritoneal dialysis, PTH parathyroid hormone, SHPTH secondary hyperparathyroidism, RAS renin-angiotensin-aldosterone system
- Modifiable risk factors of peritonitis reported in previous studies are marked with asterisks
